The recent annual meeting of the American Epilepsy Society presented landmark data confirming medical cannabis can be helpful in combatting children. In the United States alone, epilepsy affects one in 26 Americans, one third of those patients having a treatment-resistant form of the condition. The study discussed revealed that of 261 patients who received cannabidiol (CBD) treatment, the non-psychoactive extract provided the best relief for treatment resistant epilepsy. Forty-five percent of those who received the CBD treatment received a significant reduction in seizure frequency, and nine percent were seizure-free after three months. Even after the trial, some children continued to experience the benefits. Lead author of the story, Orrin Devinsky, discusses the significance of this data, saying "In the subsequent periods, which are very encouraging, nine percent of all patients and thirteen percent of those with Dravet Syndrome epilepsy were seizure-free. Many have never been seizure-free before."
This information has been provided by Alternet and approved by our Chief Medical Officer.